TABLE 2.
Characteristics of the Study Population
| Overall Cohort (n=68) |
Complete NNNS (n=51) |
|
|---|---|---|
| Birthweight* (Kilograms) | 3.4 ± 0.7 | 3.3 ± 0.7 |
| Gestational Age* (weeks) | 38.8 ± 1.9 | 38.7 ± 1.8 |
| Gender, n (%male) | 42 (62) | 32 (63) |
| Apgar | ||
| 1 minute | 2 (0–6) a | 2 (0–6) |
| 5 minute | 4 (0–9) a | 4 (0–9) |
| 10 minute | 5 (0–9) b | 5 (0–8) e |
| Presenting pH | 6.97 (6.5–7.35) | 7 (6.5–7.34) f |
| Base Deficit | 18 (8–36) d | 17 (8–36) g |
| Clinical Seizure, n (%) | 20 (29) | 11 (22)** |
| Encephalopathy Grade | ||
| Moderate | 60 (88) | 48 (94)** |
| Severe | 8 (12) | 3 (6) |
| DOL NNNS | 12 (5–20) | 12 (5–19) |
| DOL MRI | 8 (5–16) | 9 (5–16) |
Data presented as median (range) except where indicated,
*
mean ± SD
**
Significant difference between groups with and without complete NNNS (p<0.05)
Data available for
a
67,
b
56,
c
66,
d
60 of 68 patients;
e
42,
f
50,
g
46 of 51 patients